GlaxoSmithkline to axe 6,000 jobs

British drugs company GlaxoSmithKline is set to announce about 6,000 job losses when it posts results on Thursday, the 'Sunday Telegraph' newspaper said. The cuts by Glaxo, the world's second largest drugs company after U.S. group Pfizer, are part of Chief Executive Andrew Witty's strategy to meet the challenges facing the industry, including increased competition from generic drug makers, the British newspaper said.

The company, which employs about 100,000 people including 18,000 in the UK, has failed to get as many new drugs to market as investors hoped when it was created via a merger eight years ago. Witty has tried to shift Glaxo's center of gravity away from blockbuster prescription drugs, like top-seller Advair for asthma, and toward non-prescription consumer healthcare products.

A Glaxo spokesman said the company has a restructuring program but he declined to comment on specific job cuts. Rival AstraZeneca announced 6,000 job losses on Thursday after posting weaker than expected fourth-quarter sales.

Be part of XTractor community.

• XTractor the first of its kind - Literature alert service, provides manually curated & annotated sentences for the Keywords of your choice
  
• XTractor maps, extracted entities (genes, processes, drugs, diseases etc) to multiple ontologies
  
• Enables customized report generation. With XTractor the sentences are categorized into biologically significant relationships
  
• The categorized sentences could then be tagged and shared across multiple users
  
• Provides users with the ability to create his own database for a set of Key terms
  
• Users could change the Keywords of preference from time to time, with changing research needs
  
• XTractor thus proves to be a platform for getting real-time highly accurate data along with the ability to Share and collaborate
  
  

Sign up it's free, and takes less than a minute. Just click here:www.xtractor.in.